Regenerative Medical Technology Group Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Regenerative Medical Technology Group Inc. reported Cash And Cash Equivalents At Carrying Value of $530.5 thousand for the year ending 2023.

  • Regenerative Medical Technology Group Inc. showed a decrease of -67.8% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from Regenerative Medical Technology Group Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2024.
  • XBRL data for this metric is available from 2016 to 2023 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2016 to 2023), Regenerative Medical Technology Group Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 7,880.4%.
  • Historical annual values: Fiscal year 2023: $530.5 thousand | Fiscal year 2022: $1.65 million | Fiscal year 2021: $2.98 million | Fiscal year 2020: $42.5 thousand | Fiscal year 2019: $23.4 thousand | Fiscal year 2018: $30.8 thousand | Fiscal year 2017: $7.8 thousand | Fiscal year 2016: $6.6 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: